Radiation-Sensitizing Agents
"Radiation-Sensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
Concept/Terms
Radiation-Sensitizing Agents- Radiation-Sensitizing Agents
- Radiation Sensitizers
- Sensitizers, Radiation
- Radiation Sensitizing Agents
- Sensitizing Agents, Radiation
- Radiosensitizing Agents
- Agents, Radiosensitizing
- Radiosensitizing Drugs
- Drugs, Radiosensitizing
- Agents, Radiation-Sensitizing
- Agents, Radiation Sensitizing
- Radiation-Sensitizing Drugs
- Drugs, Radiation-Sensitizing
- Radiation Sensitizing Drugs
Radiation-Sensitizing Effect- Radiation-Sensitizing Effect
- Effect, Radiation-Sensitizing
- Radiation Sensitizing Effect
- Radiosensitizing Effect
- Effect, Radiosensitizing
- Radiosensitizing Effects
- Effects, Radiosensitizing
- Radiation-Sensitizing Effects
- Effects, Radiation-Sensitizing
- Radiation Sensitizing Effects
Below are MeSH descriptors whose meaning is more general than "Radiation-Sensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Radiation-Sensitizing Agents".
This graph shows the total number of publications written about "Radiation-Sensitizing Agents" by people in Harvard Catalyst Profiles by year, and whether "Radiation-Sensitizing Agents" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 0 | 3 |
| 1994 | 4 | 3 | 7 |
| 1995 | 2 | 4 | 6 |
| 1996 | 5 | 1 | 6 |
| 1997 | 3 | 2 | 5 |
| 1998 | 6 | 2 | 8 |
| 1999 | 8 | 6 | 14 |
| 2000 | 6 | 0 | 6 |
| 2001 | 5 | 3 | 8 |
| 2002 | 2 | 3 | 5 |
| 2003 | 3 | 1 | 4 |
| 2004 | 2 | 1 | 3 |
| 2005 | 4 | 1 | 5 |
| 2006 | 3 | 1 | 4 |
| 2007 | 2 | 3 | 5 |
| 2008 | 3 | 3 | 6 |
| 2009 | 2 | 4 | 6 |
| 2010 | 7 | 2 | 9 |
| 2011 | 8 | 4 | 12 |
| 2012 | 4 | 4 | 8 |
| 2013 | 4 | 5 | 9 |
| 2014 | 2 | 2 | 4 |
| 2015 | 12 | 3 | 15 |
| 2016 | 7 | 4 | 11 |
| 2017 | 4 | 4 | 8 |
| 2018 | 6 | 1 | 7 |
| 2019 | 11 | 0 | 11 |
| 2020 | 2 | 1 | 3 |
| 2021 | 4 | 4 | 8 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Radiation-Sensitizing Agents" by people in Profiles.
-
Modulation of Radiation Biomarkers in a Randomized Phase II Study of 131I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory Neuroblastoma. Int J Radiat Oncol Biol Phys. 2023 Apr 01; 115(5):1115-1128.
-
Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer. Am J Clin Oncol. 2021 09 01; 44(9):469-474.
-
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol Hepatol. 2021 10; 6(10):803-815.
-
Translation of DNA Damage Response Inhibitors as Chemoradiation Sensitizers From the Laboratory to the Clinic. Int J Radiat Oncol Biol Phys. 2021 12 01; 111(5):e38-e53.
-
Screening and Validation of Molecular Targeted Radiosensitizers. Int J Radiat Oncol Biol Phys. 2021 12 01; 111(5):e63-e74.
-
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development. Mol Cancer Ther. 2021 09; 20(9):1614-1626.
-
Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial). Radiother Oncol. 2021 07; 160:159-165.
-
Duramycin radiosensitization of MCA-RH 7777 hepatoma cells through the elevation of reactive oxygen species. J Cancer Res Ther. 2021 Apr-Jun; 17(2):543-546.
-
Olaparib increases the therapeutic index of hemithoracic irradiation compared with hemithoracic irradiation alone in a mouse lung cancer model. Br J Cancer. 2021 05; 124(11):1809-1819.
-
Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation. Cancer Lett. 2021 05 01; 505:37-48.